Zafer Gülbaş - Concepedia

Author

Zafer Gülbaş

Also Known As

C. Craddock, Gülbas, Zafer, Vânia Tietsche De Moraes Hungria, Z Gulbas, Z Gülbas, Z Gülbaş, Z. Gulbas, Z. GÜLBAŞ, Z. Gülbas, Z. Gülbaş

256

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Eskişehir Osmangazi University Sorbonne Université Hôpital Saint-Antoine Ospedale Policlinico San Martino Sheba Medical Center

About

Zafer Gülbaş is an author at Eskişehir Osmangazi University specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	35	2K
2	Health Sciences	12	14	316
3	Allergy	4	4	73
4	Engineering	1	1	14
5	Allergy Medicine	1	1	17

Zafer Gülbaş

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Michel Attal, Paul G. Richardson, S. Vincent Rajkumar, The Lancet Hematological MalignancyMedicineImmunologyHematologyPharmacotherapy	2019	620
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS Selina M. Luger, Olle Ringdén, M-J Zhang, Bone Marrow Transplantation Similar OutcomesOncologyMarrow TransplantationTransplantationHematology	2011	274
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma Philippe Armand, Scott J. Rodig, Catherine Thiéblemont, Journal of Clinical Oncology	2019	256
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group Diana Averbuch, Gloria Tridello, Jennifer Hoek, Clinical Infectious Diseases	2017	254
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide Annalisa Ruggeri, Myriam Labopin, Andrea Bacigalupo, Cancer	2018	174
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group Meral Beksaç, Rauf Haznedar, Tülin Firatli‐Tuglular, European Journal Of Haematology	2010	143
Post-transplant cyclophosphamide <i>versus</i> anti-thymocyte globulin as graft- <i>versus</i> -host disease prophylaxis in haploidentical transplant Annalisa Ruggeri, Yuqian Sun, Myriam Labopin, Haematologica ImmunologyHaploidentical TransplantImmunotherapyTranslational MedicineSevere Graft-versus-host Disease	2016	136
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL Peter Dreger, Anna Sureda, Kwang Woo Ahn, Blood Advances TransplantationMarrow TransplantationOncologyPtcy-based Haploidentical VsMalignant Blood Disorder	2019	112
Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography Olga Meltem Akay, Zeki Üstüner, Zerrin Cantürk, Medical Oncology ThrombosisHeart FailureVenous ThrombosisCardiovascular DiseasePathology	2008	106
Oxygen-free radicals impair fracture healing in rats Erol Göktürk, Akin Turgut, Cengiz Baygu, Acta Orthopaedica Scandinavica	1995	100

Page 1